Actualités CNBX Pharmaceuticals Inc (PK) - CNBX | Actions OTCMarkets

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Quarterly Report (10-q)

0001343009 false --08-31 2022 Q2

Current Report Filing (8-k)

0001343009 false 0001343009 2022-03-11 2022-03-11 iso4217:USD xbrli:shares...

Securities Registration Statement (s-1)

0001343009 false...

Current Report Filing (8-k)

0001343009 false 0001343009 2022-02-15 2022-02-15 iso4217:USD xbrli:shares...

Proxy Statement - Other Information (preliminary) (pre 14c)

SCHEDULE 14C (Rule 14c-101) Information Statement Pursuant to Section 14(c) of the...

Quarterly Report (10-q)

0001343009 false 08/31 2022 Q1 0001343009 2021-09-01 2021-11-30 0001343009 2022-01-14 0001343009 2021-11-30 0001343009 2021-08-31...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Quarterly Report (10-q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _______________ ...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:May 17,

Securities Registration Statement (s-1)

Table of Contents As Filed with the Securities and Exchange Commission on __________ __, 2021 Registration No...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Quarterly Report (10-q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

CNBX Pharmaceuticals Inc (PK) (CNBX)

Votre Hub pour des idées et discussions en direct en temps réel

CNBX Actualités

Quarterly Report (10-q)

Current Report Filing (8-k)

Securities Registration Statement (s-1)

Current Report Filing (8-k)

Proxy Statement - Other Information (preliminary) (pre 14c)

Quarterly Report (10-q)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Quarterly Report (10-q)

Current Report Filing (8-k)

Notice of Effectiveness (effect)

Securities Registration Statement (s-1)

Current Report Filing (8-k)

Quarterly Report (10-q)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

CNBX Pharmaceuticals Inc (PK) (CNBX) Actualités

CNBX Pharmaceuticals Inc (PK) (CNBX)

Votre Hub pour des idées et discussions en direct en temps réel

CNBX Actualités

Quarterly Report (10-q)

Current Report Filing (8-k)

Securities Registration Statement (s-1)

Current Report Filing (8-k)

Proxy Statement - Other Information (preliminary) (pre 14c)

Quarterly Report (10-q)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Quarterly Report (10-q)

Current Report Filing (8-k)

Notice of Effectiveness (effect)

Securities Registration Statement (s-1)

Current Report Filing (8-k)

Quarterly Report (10-q)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités